Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.240
+0.030 (2.48%)
At close: May 22, 2025, 4:00 PM
1.201
-0.039 (-3.18%)
Pre-market: May 23, 2025, 8:00 AM EDT
ZNTL's stock price has decreased by -89.29% in the past year and price targets may not have had time to catch up.
Zentalis Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$8.69
Upside
+600.81%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Reiterates $4 | Hold | Reiterates | $4 | +222.58% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +706.45% | May 15, 2025 |
| Wedbush | Wedbush | Hold Reiterates $4 | Hold | Reiterates | $4 | +222.58% | Mar 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +706.45% | Mar 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +706.45% | Mar 17, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +383.87% | Jan 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $10 | Strong Buy | Maintains | $20 → $10 | +706.45% | Jan 29, 2025 |
| UBS | UBS | Hold Maintains $5 → $2.2 | Hold | Maintains | $5 → $2.2 | +77.42% | Jan 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | +545.16% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,512.90% | Nov 15, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $20 | Buy | Reiterates | $20 | +1,512.90% | Sep 16, 2024 |
| Wedbush | Wedbush | Sell → Hold Upgrades $4 | Sell → Hold | Upgrades | $4 | +222.58% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,512.90% | Aug 12, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $28 → $5 | Strong Buy → Hold | Downgrades | $28 → $5 | +303.23% | Jun 20, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $29 → $9 | Buy → Hold | Downgrades | $29 → $9 | +625.81% | Jun 18, 2024 |
| Stifel | Stifel | Strong Buy Maintains $32 → $10 | Strong Buy | Maintains | $32 → $10 | +706.45% | Jun 18, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.